speb/financial-data huggingface dataset:
CRCL income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 90363000.00
CRCL cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
CRCL balance_sheet (annual, 2023-12-31) — Prepaid Assets: 14394000.00
CRCL income_statement (annual, 2023-12-31) — Pretax Income: 318949000.00
CRCL cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 1037000.00
CRCL balance_sheet (annual, 2023-12-31) — Properties: 0.00
CRCL cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 0.00
CRCL cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
CRCL cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -32862000.00
CRCL cash_flow (annual, 2023-12-31) — Purchase Of Investment: -314300000.00
CRCL balance_sheet (annual, 2023-12-31) — Receivables: 151336000.00
CRCL income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1023779000.00
CRCL income_statement (annual, 2023-12-31) — Reconciled Depreciation: 34887000.00
CRCL cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -8745000.00
CRCL balance_sheet (annual, 2023-12-31) — Restricted Cash: 24621961000.00
CRCL income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 0.00
CRCL balance_sheet (annual, 2023-12-31) — Retained Earnings: -1385607000.00
CRCL cash_flow (annual, 2023-12-31) — Sale Of Business: 1629000.00
CRCL cash_flow (annual, 2023-12-31) — Sale Of Investment: 8855958000.00
CRCL income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 36544000.00
CRCL income_statement (annual, 2023-12-31) — Selling General And Administration: 136672000.00
CRCL balance_sheet (annual, 2023-12-31) — Share Issued: 222540115.00
CRCL income_statement (annual, 2023-12-31) — Special Income Charges: 21634000.00
CRCL cash_flow (annual, 2023-12-31) — Stock Based Compensation: 107999000.00
CRCL balance_sheet (annual, 2023-12-31) — Stockholders Equity: 339471000.00
CRCL balance_sheet (annual, 2023-12-31) — Tangible Book Value: -157454000.00
CRCL income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 4547182.00
CRCL income_statement (annual, 2023-12-31) — Tax Provision: 47400000.00
CRCL income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.15
CRCL balance_sheet (annual, 2023-12-31) — Taxes Receivable: 25647000.00
CRCL balance_sheet (annual, 2023-12-31) — Total Assets: 25996583000.00
CRCL balance_sheet (annual, 2023-12-31) — Total Capitalization: 397958000.00
CRCL balance_sheet (annual, 2023-12-31) — Total Debt: 58487000.00
CRCL balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 339471000.00
CRCL income_statement (annual, 2023-12-31) — Total Expenses: 1216060000.00
CRCL balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 25657112000.00
CRCL balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 682672000.00
CRCL balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1219574000.00
CRCL income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 269528000.00
CRCL balance_sheet (annual, 2023-12-31) — Total Tax Payable: 27162000.00
CRCL income_statement (annual, 2023-12-31) — Total Unusual Items: 30518000.00
CRCL income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 30518000.00
CRCL balance_sheet (annual, 2023-12-31) — Treasury Stock: 2877000.00
CRCL cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -25343000.00
CRCL balance_sheet (annual, 2023-12-31) — Working Capital: 876373000.00
CRCL income_statement (annual, 2023-12-31) — Write Off: -13488000.00
CRCL cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
CRCL cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 0.00
CRCL cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
CRCL income_statement (quarterly, 2024-09-30) — Otherunder Preferred Stock Dividend: 0.00
CRCL income_statement (quarterly, 2024-09-30) — Preferred Stock Dividends: 70996000.00
CRCL income_statement (annual, 2024-12-31) — +Operating Expense: 232572000.00
CRCL income_statement (annual, 2024-12-31) — +Total Revenue: 1676253000.00
CRCL balance_sheet (annual, 2024-12-31) — Accounts Payable: 123579000.00
CRCL balance_sheet (annual, 2024-12-31) — Accounts Receivable: 145307000.00
CRCL balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -4781000.00
CRCL balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1792969000.00
CRCL income_statement (annual, 2024-12-31) — Amortization: 49000000.00
CRCL cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 49000000.00
CRCL cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 49000000.00
CRCL income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 49000000.00
CRCL cash_flow (annual, 2024-12-31) — Amortization Of Securities: -2268000.00
CRCL cash_flow (quarterly, 2024-12-31) — Amortization Of Securities: -85000.00
CRCL balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 84114000.00
CRCL balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 84114000.00
CRCL income_statement (annual, 2024-12-31) — Average Dilution Earnings: 4005000.00
CRCL income_statement (annual, 2024-12-31) — Basic Average Shares: 222540115.00
CRCL income_statement (annual, 2024-12-31) — Basic EPS: 0.08
CRCL cash_flow (annual, 2024-12-31) — Beginning Cash Position: 24994159000.00
CRCL cash_flow (annual, 2024-12-31) — Capital Expenditure: -39098000.00
CRCL cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -39098000.00
CRCL balance_sheet (annual, 2024-12-31) — Capital Stock: 6000.00
CRCL balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 750981000.00
CRCL balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 765309000.00
CRCL cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 19449891000.00
CRCL cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 186301000.00
CRCL cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 344576000.00
CRCL cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 10891000.00
CRCL cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 132878000.00
CRCL cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -21764000.00
CRCL cash_flow (annual, 2024-12-31) — Change In Receivables: -4569000.00
CRCL cash_flow (annual, 2024-12-31) — Change In Working Capital: 117436000.00
CRCL cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -4569000.00
CRCL cash_flow (annual, 2024-12-31) — Changes In Cash: 19980768000.00
CRCL balance_sheet (annual, 2024-12-31) — Common Stock: 6000.00
CRCL balance_sheet (annual, 2024-12-31) — Common Stock Equity: 570529000.00
CRCL cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
CRCL cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
CRCL balance_sheet (annual, 2024-12-31) — Construction In Progress: 16204000.00
CRCL balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 16204000.00
CRCL income_statement (annual, 2024-12-31) — Cost Of Revenue: 1280774000.00
CRCL balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 153632000.00
CRCL balance_sheet (annual, 2024-12-31) — Current Assets: 45164949000.00
CRCL balance_sheet (annual, 2024-12-31) — Current Deferred Assets: 4235000.00
CRCL balance_sheet (quarterly, 2024-12-31) — Current Deferred Assets: 4235000.00
CRCL balance_sheet (annual, 2024-12-31) — Current Liabilities: 44030967000.00
CRCL cash_flow (annual, 2024-12-31) — Deferred Income Tax: -2806000.00
CRCL cash_flow (annual, 2024-12-31) — Deferred Tax: -2806000.00
CRCL cash_flow (annual, 2024-12-31) — Depreciation: 1900000.00
CRCL cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 50854000.00
CRCL income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 50854000.00
CRCL cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 50854000.00
CRCL income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 50854000.00
CRCL income_statement (annual, 2024-12-31) — Depreciation Income Statement: 1900000.00
CRCL balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 1591000.00
CRCL balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 1591000.00
CRCL income_statement (annual, 2024-12-31) — Diluted Average Shares: 222540115.00
CRCL income_statement (annual, 2024-12-31) — Diluted EPS: 0.08
CRCL income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 22114000.00
CRCL income_statement (annual, 2024-12-31) — EBIT: 223480000.00
CRCL income_statement (annual, 2024-12-31) — EBITDA: 274334000.00
CRCL cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -7099000.00
CRCL cash_flow (annual, 2024-12-31) — End Cash Position: 44967604000.00
CRCL cash_flow (annual, 2024-12-31) — Financing Cash Flow: 19449891000.00
CRCL cash_flow (annual, 2024-12-31) — Free Cash Flow: 305478000.00
CRCL cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -13312000.00
CRCL cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 73000.00
CRCL income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 0.00
CRCL income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 12443000.00
CRCL balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 3644000.00
CRCL income_statement (annual, 2024-12-31) — General And Administrative Expense: 137283000.00
CRCL balance_sheet (annual, 2024-12-31) — Goodwill: 169544000.00
CRCL balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 500938000.00
CRCL balance_sheet (annual, 2024-12-31) — Gross PPE: 23463000.00
CRCL income_statement (annual, 2024-12-31) — Gross Profit: 395479000.00
CRCL cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 75579000.00
CRCL balance_sheet (annual, 2024-12-31) — Income Tax Payable: 678000.00
CRCL income_statement (annual, 2024-12-31) — Interest Expense: 1906000.00
CRCL income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 1906000.00
CRCL income_statement (annual, 2024-12-31) — Interest Income: 34712000.00
CRCL income_statement (annual, 2024-12-31) — Interest Income Non Operating: 34712000.00
CRCL cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 258000.00
CRCL balance_sheet (annual, 2024-12-31) — Interest Payable: 514000.00
CRCL balance_sheet (quarterly, 2024-12-31) — Interest Payable: 514000.00
CRCL balance_sheet (annual, 2024-12-31) — Invested Capital: 611246000.00
CRCL cash_flow (annual, 2024-12-31) — Investing Cash Flow: 186301000.00
CRCL balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 84114000.00
CRCL balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 84114000.00
CRCL balance_sheet (annual, 2024-12-31) — Investments And Advances: 115444000.00
CRCL cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
CRCL cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
CRCL balance_sheet (annual, 2024-12-31) — Leases: 739000.00
CRCL balance_sheet (annual, 2024-12-31) — Long Term Debt: 40717000.00
CRCL balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 40717000.00
CRCL balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 40717000.00
CRCL balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 40717000.00
CRCL balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 4920000.00
CRCL balance_sheet (annual, 2024-12-31) — Minority Interest: 0.00
CRCL balance_sheet (quarterly, 2024-12-31) — Minority Interest: 0.00
CRCL income_statement (annual, 2024-12-31) — Minority Interests: 0.00
CRCL cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
CRCL cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
CRCL cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
CRCL cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -565000.00
CRCL income_statement (annual, 2024-12-31) — Net Income: 155667000.00
CRCL income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 18109000.00
CRCL income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 156991000.00
CRCL income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: -1324000.00
CRCL income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 155667000.00
CRCL income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 156991000.00
CRCL cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 155667000.00
CRCL income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 155667000.00
CRCL cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -39098000.00
CRCL cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: -11649000.00
CRCL income_statement (annual, 2024-12-31) — Net Interest Income: 32806000.00
CRCL cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 243527000.00
CRCL income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 32806000.00
CRCL cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 19448277000.00
CRCL cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -18128000.00
CRCL balance_sheet (annual, 2024-12-31) — Net PPE: 18682000.00
CRCL cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
CRCL balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 69591000.00
CRCL balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 10223000.00
CRCL balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 29559000.00
CRCL balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 10223000.00
CRCL balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 29559000.00
CRCL income_statement (annual, 2024-12-31) — Normalized EBITDA: 261891000.00
CRCL income_statement (annual, 2024-12-31) — Normalized Income: 148168913.00
CRCL cash_flow (annual, 2024-12-31) — Operating Cash Flow: 344576000.00
CRCL cash_flow (annual, 2024-12-31) — Operating Gains Losses: -13804000.00
CRCL income_statement (annual, 2024-12-31) — Operating Income: 162907000.00
CRCL income_statement (annual, 2024-12-31) — Operating Revenue: 1669990000.00
CRCL balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 222540115.00
CRCL cash_flow (annual, 2024-12-31) — Other Cash Adjustment Outside Changein Cash: -224000.00
CRCL cash_flow (quarterly, 2024-12-31) — Other Cash Adjustment Outside Changein Cash: -134000.00
CRCL balance_sheet (annual, 2024-12-31) — Other Current Assets: 5967000.00
CRCL balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 43743960000.00
CRCL balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 3644000.00
CRCL income_statement (annual, 2024-12-31) — Other Gand A: 137283000.00
CRCL income_statement (annual, 2024-12-31) — Other Income Expense: 25861000.00
CRCL balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 331394000.00
CRCL balance_sheet (annual, 2024-12-31) — Other Investments: 115444000.00
CRCL cash_flow (annual, 2024-12-31) — Other Non Cash Items: -613000.00
CRCL balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 24173000.00
CRCL balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 21281000.00
CRCL income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 13418000.00
CRCL income_statement (annual, 2024-12-31) — Other Operating Expenses: 27109000.00
CRCL balance_sheet (annual, 2024-12-31) — Other Payable: 9118000.00
CRCL balance_sheet (annual, 2024-12-31) — Other Properties: 1600000.00
CRCL balance_sheet (annual, 2024-12-31) — Other Receivables: 6957000.00
CRCL balance_sheet (quarterly, 2024-12-31) — Other Receivables: 6957000.00
CRCL balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 14328000.00
CRCL income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 46514000.00
CRCL income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 2214000.00
CRCL balance_sheet (annual, 2024-12-31) — Payables: 133375000.00
CRCL balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 287007000.00
CRCL balance_sheet (annual, 2024-12-31) — Preferred Securities Outside Stock Equity: 1139765000.00
CRCL balance_sheet (quarterly, 2024-12-31) — Preferred Securities Outside Stock Equity: 1139765000.00
CRCL income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 91044000.00
CRCL income_statement (quarterly, 2024-12-31) — Preferred Stock Dividends: 0.00
CRCL cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
CRCL balance_sheet (annual, 2024-12-31) — Prepaid Assets: 15602000.00
CRCL income_statement (annual, 2024-12-31) — Pretax Income: 221574000.00
CRCL cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 1614000.00
CRCL balance_sheet (annual, 2024-12-31) — Properties: 0.00
CRCL cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 0.00
CRCL cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
CRCL cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -39098000.00
CRCL cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: -11649000.00
CRCL cash_flow (annual, 2024-12-31) — Purchase Of Investment: -103578000.00
CRCL balance_sheet (annual, 2024-12-31) — Receivables: 160771000.00
CRCL income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 1280774000.00
CRCL income_statement (annual, 2024-12-31) — Reconciled Depreciation: 50854000.00
CRCL cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
CRCL balance_sheet (annual, 2024-12-31) — Restricted Cash: 44213065000.00
CRCL income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
CRCL balance_sheet (annual, 2024-12-31) — Retained Earnings: -1223213000.00
CRCL cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
CRCL cash_flow (annual, 2024-12-31) — Sale Of Investment: 347105000.00
CRCL income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 17326000.00
CRCL income_statement (annual, 2024-12-31) — Selling General And Administration: 154609000.00
CRCL balance_sheet (annual, 2024-12-31) — Share Issued: 222540115.00
CRCL income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
CRCL cash_flow (annual, 2024-12-31) — Stock Based Compensation: 50134000.00
CRCL balance_sheet (annual, 2024-12-31) — Stockholders Equity: 570529000.00
CRCL balance_sheet (annual, 2024-12-31) — Tangible Book Value: 69591000.00
CRCL income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 3620913.00
CRCL income_statement (annual, 2024-12-31) — Tax Provision: 64583000.00
CRCL income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.29
CRCL balance_sheet (annual, 2024-12-31) — Taxes Receivable: 8507000.00
CRCL balance_sheet (annual, 2024-12-31) — Total Assets: 45834409000.00
CRCL balance_sheet (annual, 2024-12-31) — Total Capitalization: 611246000.00
CRCL balance_sheet (annual, 2024-12-31) — Total Debt: 40717000.00
CRCL balance_sheet (quarterly, 2024-12-31) — Total Debt: 40717000.00
CRCL balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 570529000.00
CRCL income_statement (annual, 2024-12-31) — Total Expenses: 1513346000.00
CRCL balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 45263880000.00
CRCL balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 669460000.00
CRCL balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1232913000.00
CRCL income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 167158000.00
CRCL balance_sheet (annual, 2024-12-31) — Total Tax Payable: 678000.00
CRCL income_statement (annual, 2024-12-31) — Total Unusual Items: 12443000.00
CRCL income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 12443000.00
CRCL balance_sheet (annual, 2024-12-31) — Treasury Stock: 2877000.00
CRCL cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -10024000.00
CRCL balance_sheet (annual, 2024-12-31) — Working Capital: 1133982000.00
CRCL income_statement (annual, 2024-12-31) — Write Off: -4251000.00
CRCL income_statement (quarterly, 2025-03-31) — +Operating Expense: 56096000.00
CRCL income_statement (quarterly, 2025-03-31) — +Total Revenue: 578573000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 111921000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 199092000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -4947000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1900888000.00
CRCL income_statement (quarterly, 2025-03-31) — Amortization: 13466000.00
CRCL cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 13466000.00
CRCL cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 13466000.00
CRCL income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 13466000.00
CRCL cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: 0.00
CRCL balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 77532000.00
CRCL income_statement (quarterly, 2025-03-31) — Basic Average Shares: 222540115.00
CRCL income_statement (quarterly, 2025-03-31) — Basic EPS: 0.00
CRCL cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 44967604000.00
CRCL cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -11675000.00
CRCL cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -11675000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Capital Stock: 6000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 848606000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 850796000.00
CRCL cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 16263099000.00
CRCL cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -25225000.00
CRCL cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 56593000.00
CRCL cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -2339000.00
CRCL cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 6421000.00
CRCL cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -47792000.00
CRCL cash_flow (quarterly, 2025-03-31) — Change In Receivables: -5353000.00
CRCL cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -49063000.00
CRCL cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -5353000.00
CRCL cash_flow (quarterly, 2025-03-31) — Changes In Cash: 16294467000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Common Stock: 6000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 744976000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 21144000.00
CRCL income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 423267000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 158328000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Current Assets: 61501891000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Current Deferred Assets: 6539000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 60289036000.00
CRCL cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -1250000.00
CRCL cash_flow (quarterly, 2025-03-31) — Deferred Tax: -1250000.00
CRCL cash_flow (quarterly, 2025-03-31) — Depreciation: 400000.00
CRCL cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 13880000.00
CRCL income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 13880000.00
CRCL cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 13880000.00
CRCL income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 13880000.00
CRCL income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 414000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 0.00
CRCL income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 222540115.00
CRCL income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.00
CRCL income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 0.00
CRCL income_statement (quarterly, 2025-03-31) — EBIT: 90172000.00
CRCL income_statement (quarterly, 2025-03-31) — EBITDA: 104052000.00
CRCL cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 6582000.00
CRCL cash_flow (quarterly, 2025-03-31) — End Cash Position: 61268653000.00
CRCL cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 16263099000.00
CRCL cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 44918000.00
CRCL cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 14532000.00
CRCL cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 12000.00
CRCL income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -11184000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 5369000.00
CRCL income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 30684000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Goodwill: 266089000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 600672000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Gross PPE: 28657000.00
CRCL income_statement (quarterly, 2025-03-31) — Gross Profit: 155306000.00
CRCL income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 6270000.00
CRCL cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 775000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 18377000.00
CRCL income_statement (quarterly, 2025-03-31) — Interest Expense: 335000.00
CRCL income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 335000.00
CRCL income_statement (quarterly, 2025-03-31) — Interest Income: 7965000.00
CRCL income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 7965000.00
CRCL cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 180000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Interest Payable: 15770000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Invested Capital: 782390000.00
CRCL cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -25225000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 77532000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 99533000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Leases: 885000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 37414000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 37414000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 4888000.00
CRCL income_statement (quarterly, 2025-03-31) — Minority Interests: 0.00
CRCL cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -7440000.00
CRCL cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 900000.00
CRCL income_statement (quarterly, 2025-03-31) — Net Income: 64791000.00
CRCL income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 0.00
CRCL income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 64791000.00
CRCL income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 64791000.00
CRCL income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 64791000.00
CRCL cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 64791000.00
CRCL income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 64791000.00
CRCL cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -11675000.00
CRCL income_statement (quarterly, 2025-03-31) — Net Interest Income: 7630000.00
CRCL cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -246000.00
CRCL income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 7630000.00
CRCL cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 16262457000.00
CRCL cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -5864000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Net PPE: 23710000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 144304000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 10414000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 29494000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 10414000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 29494000.00
CRCL income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 121506000.00
CRCL income_statement (quarterly, 2025-03-31) — Normalized Income: 77378932.74
CRCL cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 56593000.00
CRCL cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 15444000.00
CRCL income_statement (quarterly, 2025-03-31) — Operating Income: 99210000.00
CRCL income_statement (quarterly, 2025-03-31) — Operating Revenue: 578248000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 222540115.00
CRCL cash_flow (quarterly, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: 0.00
CRCL balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 7126000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 59993217000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 5369000.00
CRCL income_statement (quarterly, 2025-03-31) — Other Gand A: 30684000.00
CRCL income_statement (quarterly, 2025-03-31) — Other Income Expense: -17003000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 334583000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Other Investments: 22001000.00
CRCL cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -3371000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 26177000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 20975000.00
CRCL income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 451000.00
CRCL income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 7672000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Other Payable: 7193000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Other Properties: 1740000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 2190000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Payables: 137491000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 295819000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Preferred Securities Outside Stock Equity: 1140502000.00
CRCL income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 64791000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 20628000.00
CRCL income_statement (quarterly, 2025-03-31) — Pretax Income: 89837000.00
CRCL cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 642000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
CRCL cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 1064000.00
CRCL cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -7440000.00
CRCL cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -11675000.00
CRCL cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -338000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Receivables: 200339000.00
CRCL income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 423267000.00
CRCL income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 13880000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 60416463000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1158410000.00
CRCL cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 92000.00
CRCL income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 3860000.00
CRCL income_statement (quarterly, 2025-03-31) — Selling General And Administration: 34544000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Share Issued: 227500115.00
CRCL income_statement (quarterly, 2025-03-31) — Special Income Charges: -6270000.00
CRCL cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 12716000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 744976000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 144304000.00
CRCL income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -4866067.26
CRCL income_statement (quarterly, 2025-03-31) — Tax Provision: 25046000.00
CRCL income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.28
CRCL balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 1247000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Total Assets: 62262397000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 782390000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Total Debt: 37414000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 744976000.00
CRCL income_statement (quarterly, 2025-03-31) — Total Expenses: 479363000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 61517421000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 760506000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1228385000.00
CRCL income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 92940000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 18377000.00
CRCL income_statement (quarterly, 2025-03-31) — Total Unusual Items: -17454000.00
CRCL income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -17454000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 4960000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 2877000.00
CRCL cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 2382000.00
CRCL balance_sheet (quarterly, 2025-03-31) — Working Capital: 1212855000.00
CRCL income_statement (quarterly, 2025-06-30) — +Operating Expense: 74019000.00
CRCL income_statement (quarterly, 2025-06-30) — +Total Revenue: 658078000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 222548000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 201112000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -5439000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 3998827000.00
CRCL income_statement (quarterly, 2025-06-30) — Amortization: 600000.00
CRCL income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 600000.00
CRCL cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: 0.00
CRCL balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 83794000.00
CRCL income_statement (quarterly, 2025-06-30) — Basic Average Shares: 107514000.00
CRCL income_statement (quarterly, 2025-06-30) — Basic EPS: -4.48
CRCL cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 61268653000.00
CRCL cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -13183000.00
CRCL cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -13183000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Capital Stock: 25000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1118119000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1118651000.00
CRCL cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 1533962000.00
CRCL cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -20883000.00
CRCL cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 247123000.00
CRCL cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -2001000.00
CRCL cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 117560000.00
CRCL cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 5688000.00
CRCL cash_flow (quarterly, 2025-06-30) — Change In Receivables: -3282000.00
CRCL cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 117965000.00
CRCL cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -3282000.00
CRCL cash_flow (quarterly, 2025-06-30) — Changes In Cash: 1760202000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Common Stock: 25000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 2370831000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 0.00
CRCL income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 910334000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 174752000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Current Assets: 63302129000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Current Debt: 206140000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 206140000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Current Deferred Assets: 0.00
CRCL balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 61730434000.00
CRCL cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -4501000.00
CRCL cash_flow (quarterly, 2025-06-30) — Deferred Tax: -4501000.00
CRCL cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 14209000.00
CRCL income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 14209000.00
CRCL cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 14209000.00
CRCL income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 14209000.00
CRCL income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 13600000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 0.00
CRCL income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 107514000.00
CRCL income_statement (quarterly, 2025-06-30) — Diluted EPS: -4.48
CRCL income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -482100000.00
CRCL income_statement (quarterly, 2025-06-30) — EBIT: -485659000.00
CRCL income_statement (quarterly, 2025-06-30) — EBITDA: -471450000.00
CRCL cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 46665000.00
CRCL cash_flow (quarterly, 2025-06-30) — End Cash Position: 63075520000.00
CRCL cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 1533962000.00
CRCL cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 233940000.00
CRCL cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -5927000.00
CRCL income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -161798000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 15366000.00
CRCL income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 43140000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Goodwill: 266384000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 663353000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Gross PPE: 29243000.00
CRCL income_statement (quarterly, 2025-06-30) — Gross Profit: -252256000.00
CRCL cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 12750000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 3850000.00
CRCL income_statement (quarterly, 2025-06-30) — Interest Expense: 344000.00
CRCL income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 344000.00
CRCL income_statement (quarterly, 2025-06-30) — Interest Income: 9952000.00
CRCL income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 9952000.00
CRCL cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 0.00
CRCL balance_sheet (quarterly, 2025-06-30) — Invested Capital: 2576971000.00
CRCL cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -20883000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 83794000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 118907000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Leases: 20107000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 5223000.00
CRCL cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -294000.00
CRCL cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 7863000.00
CRCL income_statement (quarterly, 2025-06-30) — Net Income: -482100000.00
CRCL income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -482100000.00
CRCL income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -482100000.00
CRCL income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -482100000.00
CRCL income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -482100000.00
CRCL cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -482100000.00
CRCL income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -482100000.00
CRCL cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -13183000.00
CRCL income_statement (quarterly, 2025-06-30) — Net Interest Income: 9608000.00
CRCL cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -5851000.00
CRCL income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 9608000.00
CRCL cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 955246000.00
CRCL cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -1555000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Net PPE: 23804000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1707478000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 17472000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 31812000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 17472000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 31812000.00
CRCL income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -309652000.00
CRCL income_statement (quarterly, 2025-06-30) — Normalized Income: -321596384.00
CRCL cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 247123000.00
CRCL cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 1924000.00
CRCL income_statement (quarterly, 2025-06-30) — Operating Income: -326275000.00
CRCL income_statement (quarterly, 2025-06-30) — Operating Revenue: 657883000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 228565004.00
CRCL cash_flow (quarterly, 2025-06-30) — Other Cash Adjustment Outside Changein Cash: 0.00
CRCL balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 7581000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 206140000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 61112734000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 15366000.00
CRCL income_statement (quarterly, 2025-06-30) — Other Gand A: 43140000.00
CRCL income_statement (quarterly, 2025-06-30) — Other Income Expense: -169336000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 396969000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Other Investments: 35113000.00
CRCL cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -3739000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 27843000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 20431000.00
CRCL income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -7538000.00
CRCL income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 8760000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Other Payable: 10410000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Other Properties: 3913000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 532000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Payables: 236808000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 411560000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Preferred Securities Outside Stock Equity: 0.00
CRCL balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 19027000.00
CRCL income_statement (quarterly, 2025-06-30) — Pretax Income: -486003000.00
CRCL cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 6158000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
CRCL cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 4501000.00
CRCL cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -294000.00
CRCL cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -13183000.00
CRCL cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -6032000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Receivables: 202679000.00
CRCL income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 910334000.00
CRCL income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 14209000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 61954191000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1640510000.00
CRCL cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 181000.00
CRCL income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 7910000.00
CRCL income_statement (quarterly, 2025-06-30) — Selling General And Administration: 51050000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Share Issued: 233525004.00
CRCL cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 431140000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 2370831000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1707478000.00
CRCL income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -1294384.00
CRCL income_statement (quarterly, 2025-06-30) — Tax Provision: -3903000.00
CRCL income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.01
CRCL balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 1567000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Total Assets: 64153508000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 2370831000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Total Debt: 206140000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 2370831000.00
CRCL income_statement (quarterly, 2025-06-30) — Total Expenses: 984353000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 61782677000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 851379000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 52243000.00
CRCL income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -325582000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 3850000.00
CRCL income_statement (quarterly, 2025-06-30) — Total Unusual Items: -161798000.00
CRCL income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -161798000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 4960000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 2877000.00
CRCL cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: 167724000.00
CRCL balance_sheet (quarterly, 2025-06-30) — Working Capital: 1571695000.00
CRCL income_statement (quarterly, 2025-09-30) — +Operating Expense: 83503000.00
CRCL income_statement (quarterly, 2025-09-30) — +Total Revenue: 739759000.00
CRCL balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 35892000.00
CRCL balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 243683000.00
CRCL balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -6278000.00
CRCL balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 4437594000.00
CRCL cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: 0.00